Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Rhea-AI Summary

Anika Therapeutics, a leader in early intervention orthopedics, announced it will release its first quarter 2023 financial results on May 9, 2023, after market close. The company will host a conference call at 5:00 p.m. ET on the same day to discuss the financial results and key business highlights. Investors can join the conference call by dialing the toll-free number or through an audio webcast available on Anika's website. Anika focuses on joint preservation and minimally invasive orthopedic solutions, addressing areas such as Osteoarthritis Pain Management and Regenerative Solutions, enhancing active living for individuals worldwide.

Positive

• Anika Therapeutics is focused on high opportunity orthopedic segments.
• Plans to discuss key business highlights in the upcoming conference call.

Negative

• None.

BEDFORD, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2023 financial results after the close of the market on Tuesday, May 9, 2023 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.

The conference call can be accessed by dialing 1-888-886-7786 (toll-free domestic) or 1-416-764-8658 (international) and providing the conference ID number 53307083. A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com

FAQ

When will Anika Therapeutics release its first quarter 2023 financial results?

Anika Therapeutics will release its first quarter 2023 financial results on May 9, 2023.

What time is the Anika Therapeutics conference call scheduled?

The conference call is scheduled for May 9, 2023, at 5:00 p.m. ET.

How can I access Anika Therapeutics' conference call?

You can access the conference call by dialing 1-888-886-7786 (toll-free) or 1-416-764-8658 (international), using the conference ID number 53307083.

Where can I find the webcast for Anika Therapeutics' earnings call?

The live audio webcast will be available in the Investor Relations section of Anika's website.

What areas does Anika Therapeutics focus on?

Anika Therapeutics focuses on Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine, and Arthrosurface Joint Solutions.